BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24999683)

  • 1. 18F-FDG PET/CT in a seldom case of primary duodenal dermatofibrosarcoma protuberans with lung and skeletal metastases.
    Karunanithi S; Jain TK; Singh A; Bal C; Kumar R
    Clin Nucl Med; 2015 Feb; 40(2):e140-2. PubMed ID: 24999683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent dermatofibrosarcoma protuberans with pulmonary metastases presenting twelve years after initial diagnosis: 18F-FDG PET/CT imaging findings.
    Suman S; Sharma P; Jain TK; Sahoo MK; Bal C; Kumar R
    Clin Nucl Med; 2014 Jan; 39(1):77-8. PubMed ID: 23531730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Case of Massive Bone Metastases From Lung Cancer Detected Only by 18F-FDG PET/CT.
    Satoh Y; Koizumi K; Nambu A; Araki T
    Clin Nucl Med; 2015 Aug; 40(8):e411-4. PubMed ID: 26018679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of 68Ga-FAPI and 18F-FDG PET/CT in Dermatofibrosarcoma Protuberans.
    Wu J; Zhang S; Rao Z; Wang Y; Zhang C
    Clin Nucl Med; 2022 Jul; 47(7):629-631. PubMed ID: 35452009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-FDG PET/CT Prediction of an Aggressive Clinical Course for Dermatofibrosarcoma Protuberans.
    Basu S; Goliwale F
    J Nucl Med Technol; 2016 Jun; 44(2):88-9. PubMed ID: 26338485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients.
    Wu Y; Li P; Zhang H; Shi Y; Wu H; Zhang J; Qian Y; Li C; Yang J
    Int J Cancer; 2013 Jan; 132(2):E37-47. PubMed ID: 22890912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiologic-Pathologic Correlations of Fibrosarcomatous Dermatofibrosarcoma Protuberans With Various Histological Features on Enhanced MRI and PET/MRI.
    Hakozaki M; Yamada H; Hasegawa O; Watanabe K; Konno S
    Clin Nucl Med; 2016 Mar; 41(3):241-3. PubMed ID: 26704730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDG PET/CT differentiating two malignant tumors in the same patient.
    Shai A; Leitzin L; Steiner M; Peer A; Srour S; Shalom RB
    Acta Oncol; 2012 Jan; 51(1):142-4. PubMed ID: 21851187
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of Pretreatment Combined (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Staging on Radiation Therapy Treatment Decisions in Locally Advanced Breast Cancer.
    Ng SP; David S; Alamgeer M; Ganju V
    Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):111-7. PubMed ID: 26279029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intramedullary metastasis detected with 18F FDG-PET/CT.
    Sari O; Kaya B; Kara Gedik G; Ozcan Kara P; Varoglu E
    Rev Esp Med Nucl Imagen Mol; 2012 Sep; 31(5):299-300. PubMed ID: 23067538
    [No Abstract]   [Full Text] [Related]  

  • 11. 18F-FDG PET/CT of Bronchial Mucous Gland Adenoma.
    Cho J; Eo JS; In KH; Kim CH; Choe JG
    Clin Nucl Med; 2016 Feb; 41(2):e118-9. PubMed ID: 26252327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Case of Lung Squamous Cell Carcinoma With Duodenal Metastasis on FDG PET/CT.
    Cheng G
    Clin Nucl Med; 2016 Aug; 41(8):659-60. PubMed ID: 27055139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic undifferentiated spindle cell sarcoma of the thyroid gland evaluated by 18F-FDG PET/CT.
    Treglia G; Bongiovanni M; Paone G; Ceriani L; Giovanella L
    Clin Nucl Med; 2015 Mar; 40(3):e208-10. PubMed ID: 25140545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomography and bone metastases.
    Fogelman I; Cook G; Israel O; Van der Wall H
    Semin Nucl Med; 2005 Apr; 35(2):135-42. PubMed ID: 15765376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of FDG PET/CT in Patient Management and Outcome of Skeletal and Soft Tissue Sarcomas.
    Sheikhbahaei S; Marcus C; Hafezi-Nejad N; Taghipour M; Subramaniam RM
    PET Clin; 2015 Jul; 10(3):375-93. PubMed ID: 26099673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discordant findings in patients with non-small-cell lung cancer: absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography.
    Ak I; Sivrikoz MC; Entok E; Vardareli E
    Eur J Cardiothorac Surg; 2010 Apr; 37(4):792-6. PubMed ID: 20015657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lobular breast carcinoma: a case of rare possible 18F-FDG PET/CT and bone scan false negative.
    Maffione AM; Lisato LC; Rasi A; Marzola MC; Colletti PM; Rubello D
    Clin Nucl Med; 2015 Feb; 40(2):e134-6. PubMed ID: 24999681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herniation pit mimicking osseous metastasis on 18F-FDG PET/CT in patient with lung cancer.
    Yoo SW; Song HC; Oh JR; Kim J; Kang SR; Chong A; Byun BH; Hong SP; Min JJ; Bom HS
    Clin Nucl Med; 2012 Jul; 37(7):682-3. PubMed ID: 22691513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the diagnostic accuracy of 99 m-Tc-MDP bone scintigraphy and 18 F-FDG PET/CT for the detection of skeletal metastases.
    Chang CY; Gill CM; Joseph Simeone F; Taneja AK; Huang AJ; Torriani M; Bredella MA
    Acta Radiol; 2016 Jan; 57(1):58-65. PubMed ID: 25533313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-FDG PET/CT superscan in prostate cancer.
    Bailly M; Besse H; Kerdraon R; Metrard G; Gauvain S
    Clin Nucl Med; 2014 Oct; 39(10):912-4. PubMed ID: 24566401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.